1. Home
  2. Browse
  3. Bone & Joint
  4. Rheumatoid Arthritis
  5. Drug Toxicity

Drug Toxicity

16 - 27 of 27 Results
Sort Results:
Article: Xeljanz (ZEL-jans, tofacitinib), a new ORAL tablet for moderate to severe rheumatoid arthritis in adults September 2014
Commentary: DMARDs in the Treatment of Rheumatoid Arthritis September 2014
Article: Recent warnings about acetaminophen will raise questions about serious drug-induced skin reactions October 2013
Commentary: Serious Skin Reactions with Acetaminophen October 2013
Article: drug interaction alerts between methotrexate and "PPI" stomach acid reducers (omeprazole, pantoprazole, etc) December 2012
Commentary: Proton Pump Inhibitor-Methotrexate Interaction December 2012
Article: Many patients with rheumatoid arthritis will end up taking multiple meds July 2012
Guideline: 2012 Update of the 2008 American College of Rheumatology Recommendations for the Use of Disease-Modifying Antirheumatic Drugs and Biologic Agents in the Treatment of Rheumatoid Arthritis July 2012
Guideline: Canadian Rheumatology Association Recommendations for Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs (2011) July 2012
Patient Education: What I Need to Know About My Rheumatoid Arthritis Medication August 2009
Guideline: Use of Disease-Modifying Antirheumatic Drugs (DMARDs) in Rheumatoid Arthritis (2008) June 2009
Commentary: Simponi (Golimumab): A Monthly Injectable Drug for Arthritis June 2009